NCT00590824 2019-11-21Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV MelanomaUniversity of Wisconsin, MadisonPhase 2 Completed23 enrolled 22 charts
NCT00109863 2019-11-19Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced MelanomaUniversity of Wisconsin, MadisonPhase 2 Completed14 enrolled